ATE361378T1 - Screeningverfahren auf anti-protease resistenz hiv-2-haltiger zellen, ausgehend von biologischen patientenproben - Google Patents

Screeningverfahren auf anti-protease resistenz hiv-2-haltiger zellen, ausgehend von biologischen patientenproben

Info

Publication number
ATE361378T1
ATE361378T1 AT00949555T AT00949555T ATE361378T1 AT E361378 T1 ATE361378 T1 AT E361378T1 AT 00949555 T AT00949555 T AT 00949555T AT 00949555 T AT00949555 T AT 00949555T AT E361378 T1 ATE361378 T1 AT E361378T1
Authority
AT
Austria
Prior art keywords
screening method
cells containing
patient samples
protease resistance
containing hiv
Prior art date
Application number
AT00949555T
Other languages
English (en)
Inventor
Jean-No L Telles
Francoise Brun-Vezinet
Diane Descamps
Original Assignee
Bio Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux filed Critical Bio Merieux
Application granted granted Critical
Publication of ATE361378T1 publication Critical patent/ATE361378T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT00949555T 1999-06-21 2000-06-21 Screeningverfahren auf anti-protease resistenz hiv-2-haltiger zellen, ausgehend von biologischen patientenproben ATE361378T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907855A FR2798385B1 (fr) 1999-06-21 1999-06-21 Procede de recherche d'une resistance aux anti-proteases chez des souches du virus vih-2

Publications (1)

Publication Number Publication Date
ATE361378T1 true ATE361378T1 (de) 2007-05-15

Family

ID=9547071

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00949555T ATE361378T1 (de) 1999-06-21 2000-06-21 Screeningverfahren auf anti-protease resistenz hiv-2-haltiger zellen, ausgehend von biologischen patientenproben

Country Status (8)

Country Link
US (4) US6794129B1 (de)
EP (1) EP1185713B1 (de)
AT (1) ATE361378T1 (de)
AU (1) AU6287500A (de)
DE (1) DE60034673T2 (de)
ES (1) ES2286030T3 (de)
FR (1) FR2798385B1 (de)
WO (1) WO2000078990A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8160007B2 (en) * 2007-11-20 2012-04-17 Qualcomm Incorporated Opportunistic uplink scheduling
US8160602B2 (en) * 2007-11-20 2012-04-17 Qualcomm Incorporated Opportunistic uplink scheduling
US8547857B2 (en) * 2007-11-20 2013-10-01 Qualcomm Incorporated Opportunistic uplink scheduling
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
WO2013106807A1 (en) 2012-01-13 2013-07-18 Curry John D Scalable characterization of nucleic acids by parallel sequencing
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US11118216B2 (en) 2015-09-08 2021-09-14 Affymetrix, Inc. Nucleic acid analysis by joining barcoded polynucleotide probes
CN113113282B (zh) * 2021-04-01 2023-11-14 北京北方华创微电子装备有限公司 上电极电源功率调节方法、半导体工艺设备

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8912496D0 (en) * 1989-05-31 1989-07-19 Medical Res Council Vaccines
ATE423856T1 (de) * 1989-06-02 2009-03-15 Pasteur Institut Nukleotid-sequenzen von hiv-1, hiv-2 und siv retrovirusgenomen, ihre verwendung zur amplifizierung von pol-sequenzen dieser retroviren und zur in vitro diagnostik von diesen viren verursachten infektionen
US5436131A (en) * 1993-04-02 1995-07-25 Merck & Co., Inc. Color screening assay for identifying inhibitor resistant HIV protease mutants
US6063562A (en) * 1994-09-16 2000-05-16 Sepracor, Inc. In vitro method for predicting the evolutionary response of HIV protease to a drug targeted thereagainst
BR9704637A (pt) * 1996-01-26 1998-06-09 Innogenetics Nv Processo para deteção de mutações induzidas por droga no gene de transcrição reversa
JP2002508158A (ja) * 1998-01-30 2002-03-19 セプラコール, インク. 遺伝子調節因子融合タンパク質及びタンパク質を標的とする薬物に対する該タンパク質の抵抗性を決定するためのその使用方法
AU762811B2 (en) * 1998-06-24 2003-07-03 Innogenetics N.V. Method for detection of drug-selected mutations in the HIV protease gene

Also Published As

Publication number Publication date
ES2286030T3 (es) 2007-12-01
US20090253122A1 (en) 2009-10-08
WO2000078990A3 (fr) 2001-03-01
FR2798385B1 (fr) 2003-09-05
AU6287500A (en) 2001-01-09
WO2000078990A2 (fr) 2000-12-28
EP1185713A2 (de) 2002-03-13
US20040224311A1 (en) 2004-11-11
EP1185713B1 (de) 2007-05-02
DE60034673D1 (de) 2007-06-14
US20100209903A1 (en) 2010-08-19
FR2798385A1 (fr) 2001-03-16
US7632635B2 (en) 2009-12-15
US6794129B1 (en) 2004-09-21
DE60034673T2 (de) 2008-01-17

Similar Documents

Publication Publication Date Title
ATE361378T1 (de) Screeningverfahren auf anti-protease resistenz hiv-2-haltiger zellen, ausgehend von biologischen patientenproben
Loreille et al. Ancient DNA from Ascaris: extraction amplification and sequences from eggs collected in coprolites
AU2007226362B2 (en) Purification method and kits
DE69632466D1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
DE69016079D1 (de) Methode zur Extraktion, Amplifikation und zum Nachweis einer Nukleinsäure aus einer Fraktion mononuklearer Zellen von peripherem Blut.
CN110343751A (zh) 一种检测CRISPR-Cas9脱靶效应的方法
DE69233553D1 (de) Dns "typing" mit kurzen tandem-repetitiven polimorphismen und identifikation von kurzen polimorphen tandem-wiederholungen
ATE79474T1 (de) Verfahren zum in vitro-nachweis und bestimmung unbekannter pathogene oder genetischer einheiten.
DK0657530T3 (da) Fremgangsmåde til bestemmelse af tilstedeværelsen af en organisme i en fysiologisk prøve
DK0950113T3 (da) Detektion af genetisk prædisposition for synstruende diabetisk retinopati
Nassuth et al. Localization of genetic information involved in the replication of alfalfa mosaic virus
Bensch et al. The use of molecular methods in studies of avian haemosporidians
RU2007127447A (ru) Способ детекции hpv, а также зонды, праймеры и наборы
Noireau et al. Sylvatic triatomines (Hemiptera: Reduviidae) in Bolivia: trends toward domesticity and possible infection with Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae)
CN115976227A (zh) 一种基于CpG-SNP连锁标记的血液来源鉴定及个人识别的试剂盒以及检测方法
Li et al. Sequence‐related amplified polymorphism, an effective molecular approach for studying genetic variation in Fasciola spp. of human and animal health significance
Imperial et al. Variation in the viroid-like RNA associated with cadang-cadang disease: Evidence for an increase in molecular weight with disease progress
Sako et al. Loop-mediated isothermal amplification method for a differential identification of human Taenia tapeworms
Kamusoko et al. Purification and Amplification of DNA from cellulolytic Bacteria: Application for Biogas production from crop residues
Petersen et al. Phenolphthalein false‐positive reactions from legume root nodules
Weiss et al. Characterization of murine coronavirus RNA by hybridization with virus-specific cDNA probes
Burrows The use of DNA to identify plant parasitic nematodes.
Argyros et al. Evaluation of a PCR primer based on the isocitrate dehydrogenase gene for detection of Helicobacter pylori in feces
Samarakoon et al. A molecular key for the identification of blow flies in southeastern Nebraska
Teixeira et al. Evidence for a natural hybrid of peacock bass (Cichla monoculus vs Cichla temensis) based on esterase electrophoretic patterns

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties